SURF News and Press, Surface Oncology Inc. From 10/12/20

Gainers: iHuman (IH) +44%.Dillard's (DDS) +37%.Acorn International (ATV) +36%.Wah Fu Education (WAFU) +29%.Lizhi (LIZI) +29%.Apex Global Brands (APEX) +25%.WiMi Hologram Cloud (WIMI) +25%.Surface Oncology (SURF) +19%.Skillful Craftsman Education Technology (EDTK) +16%.Reliv' Internationa...

CAMBRIDGE, Mass., Sept. 16, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, its chief executive officer, and Robert Ross, M...

CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) --  Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, its chief executive officer, and Robert Ro...

Jounce Therapeutics ( JNCE ) is a small biotechnology company focused on the rapidly expanding industry of immuno-oncology. Armed with a productive drug discovery platform, a unique mid-stage lead candidate in lung cancer, and a penchant for striking lucrative deals with big pharma, the future...

CAMBRIDGE, Mass., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today announced that Jeff Goater, its chief executive officer, and Robert Ross, M....

Surface Oncology (NASDAQ: SURF ) wrapped up after-hours trading up 5.8% after drawing a new Outperform rating from Wedbush. More news on: Surface Oncology, Inc., Healthcare stocks news, Stocks on the move, Read more ...

The following slide deck was published by Surface Oncology, Inc. in conjunction with this Read more ...

Surface Oncology (NASDAQ: SURF ) : Q2 GAAP EPS of -$0.44 beats by $0.07 . Cash, cash equivalents and marketable securities of $112.5M. Expects current cash and cash equivalents are sufficient to fund the Company into 2022. More news on: Surface Oncology, Inc., Earnings news and comme...

CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today reported financial results and corporate highlights for the second quart...

Volatility watch: Some of the volatility names to watch include Nokia (NYSE: NOK ) , Kroger (NYSE: KR ) , Alexandria Real Estate (NYSE: ARE ) and Dave & Buster's Entertainment (NASDAQ: PLAY ) with short interest positions on the rise. Traders are also taking dead aim at retail n...